Evaluation of Rumination, Frailty and Tanatophobia in Cancer Patients Over 65 Years of Age

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

180 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-05-25

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to evaluate tanatophobia and rumination in individuals over 65 years of age receiving cancer chemotherapy and to determine the related factors.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Anxiety and Depression Perceived by Individuals With and Without Cancer During the COVID-19 Pandemic Period

NCT04698044

Anxiety Depression Covid19 +2 more

COMPLETED

Reminiscence-Based Life Review on Copying With Existential Suffering Among Older Cancer Survivors

NCT05525299

Existential Suffering Meaning of Life Cognitive Function +2 more

UNKNOWN NA

Existential Issues in Elderly People With Cancer

NCT01309815

Cancer

COMPLETED

Identify the Obstacles to Early Diagnosis of Cancer in Patients Over 75 Years Old, on an Outpatient Basis

NCT04395040

Cancer Aging

COMPLETED

Chemotherapy-induced Circadian Rhythm Disruption

NCT04364347

Breast Neoplasms

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

No studies were found in the literature evaluating the relationship between frailty and lack of social support with tanatophobia and rumination. The aim of this study is to evaluate tanatophobia and rumination in individuals over 65 years of age receiving cancer chemotherapy and to determine the related factors.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Death Rumination Frailty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 65 years or older
* Conscious and no communication problems
* Being literate
* Willing to participate in our study voluntarily
* Cancer patient receiving active chemotherapy treatment

Exclusion Criteria

* Not being willing to participate in the research
* Serious life-threatening condition (critical illness, intensive care unit stay, acute complication)
* Dementia, Alzheimer's, cognitive dysfunction
* Major psychiatric illness

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No